Concepedia

Vahid Farrokhi

VF

Statistics

Publications

11

Citations

492

H-Index

11

Active since

2013

Affiliations

Pfizer (United States)(Current)

University of Connecticut

University of North Carolina at Chapel Hill

Nantes Université

Inserm

Vahid Farrokhi is an author at Pfizer (United States) specializing in proteomics, life sciences, and molecular biology.

ORCID

Publications per year

2013–2023

11

Publications

11

Bacterial lipodipeptide, Lipid 654, is a microbiome‐associated biomarker for multiple sclerosis

Vahid Farrokhi, Reza Nemati, Frank C. Nichols et al. · Clinical & Translational Immunology · 2013 · 109 citations · Full text

, , +17

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)

Steven P. Piccoli, Devangi Mehta, Alessandra Vitaliti et al. · Bioanalysis · 2019 · 95 citations · Full text

, , +13

Serine Lipids of Porphyromonas gingivalis Are Human and Mouse Toll-Like Receptor 2 Ligands

Robert B. Clark, Jorge Cervantes, Mark W. Maciejewski et al. · Infection and Immunity · 2013 · 84 citations · Full text

, , +17

Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities

Vahid Farrokhi, J Chabot, Hendrik Neubert et al. · Scientific Reports · 2018 · 46 citations · Full text

, , +16

Human FcRn Tissue Expression Profile and Half-Life in PBMCs

Yao‐Yun Fan, Vahid Farrokhi, Teresa Caiazzo et al. · Biomolecules · 2019 · 37 citations · Full text

, , +16

1–5 of 11